Table 1 Baseline characteristics of LUAD cancer patients.
Characteristic* | DL cohort | TCGA |
|---|---|---|
Total N = 111 | Total N = 232 | |
Age | ||
 Median, IQR | 61 (55–68) | 65 (59–73) |
Sex (Male/Female) | ||
 Male | 28 (25.2%) | 102 (43.9%) |
 Female | 83 (74.7%) | 130 (56.0%) |
Stage | ||
 I | 78 (70.2%) | 147 (63.3%) |
 II | 9 (8.1%) | 53 (22.8%) |
 III | 21 (18.9%) | 24 (10.3%) |
 IV | 3 (2.7%) | 8 (3.4%) |
Status of recurrence (one year) | ||
 Recurrence | 5 (4.5%) | 32 (13.7%) |
 Non-Recurrence | 106 (95.4%) | 155 (66.8%) |
 Unknown | 0 | 45 (19.3%) |
Status of recurrence (three year) | ||
 Recurrence | 10 (9.0%) | 81 (34.9%) |
 Non-Recurrence | 97 (87.3%) | 47 (20.2%) |
 Unknown | 4 (3.6%) | 104 (44.8%) |
Status of recurrence (five year) | ||
 Recurrence | 7 (6.3%) | 86 (37%) |
 Non-Recurrence | 90 (81.0%) | 21 (9.0%) |
 Unknown | 14 (12.6%) | 125 (53.8%) |
